Single-Dose Bioequivalence Study Comparing Two 2 mg Nicotine Lozenges
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Smoking Cessation
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: Single (Outcomes Assessor)Primary Purpose: Other
Participation Requirements
- Age
- Between 18 years and 55 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03432273
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Yolandi Swart, Dr. PAREXEL (South Africa)
Get Well Soon